Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 5.12.2024Zentiva, k.s. (ZNT-1)30108Zenadea (tbl flm 3x21 (blis.PVC/PVDC/Al))31.3.2025Z
 5.12.2024KRKA, d.d., Novo mesto (KRK-2)06340Ifirmacombi 300 mg/12,5 mg filmom obalené tablety (tbl flm 28x300 mg/12,5 mg (blis.OPA/Al/PVC/Al))9.12.2024R
 5.12.2024KRKA, d.d., Novo mesto (KRK-2)45768Zalasta 15 mg orodispergovateľné tablety (tbl oro 70x15 mg)9.12.2024R
 5.12.2024KRKA, d.d., Novo mesto (KRK-2)95363Tanyz (cps mdd 100x0,4 mg (blis.PVC/PE/PVDC/Al))9.12.2024R
 5.12.2024B.Braun Melsungen AG (BME)5009BAqua pro injectione Braun (lif par 10x1000 ml (fľ.LDPE))5.12.2024R
 5.12.2024B.Braun Melsungen AG (BME)26927Kaliumchlorid B. Braun 7,45 % (con inf 20x100 ml (liek.inj.skl.))5.12.2024O
 5.12.2024Merck Europe B.V. (MCK-NL)28603Cetrotide 0,25 mg prášok a rozpúšťadlo na injekčný roztok (plv iol 1x0,25 mg + 1 ml solv. (liek.inj.skl.+striek.inj.napl.skl.))5.12.2024O
 5.12.2024CSL Behring GmbH (CSL)3675CAFSTYLA 500 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x500 IU+2,5 ml solv. (liek.inj.skl.))4.12.2024R
 5.12.2024CSL Behring GmbH (CSL)3676CAFSTYLA 1000 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x1000 IU+2,5 ml solv. (liek.inj.skl.))4.12.2024R
 5.12.2024STADA Arzneimittel AG (STD)5916EAzelastín/Flutikazón STADA (aer nau 1x23 g (fľ.skl.jantár.))9.12.2024R
 4.12.2024ratiopharm GmbH (RAT)6548BEporatio 30000 IU/1,0 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 6x1,0 ml/30000 IU ( striek.skl.napl. s bezpeč.ihlou))3.12.2024U
 4.12.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3267BPramipexol Teva Pharma 0,26 mg (tbl plg 30x0,26 mg (blis.OPA/Al/PVC/Al))31.12.2024R
 4.12.2024Teva B.V. (TEV-NL-4)81600Pirabene 1200 mg (tbl flm 60x1200 mg (blis.PVC/Al))15.1.2025R
 4.12.2024GlaxoSmithKline (Ireland) Limited (GAG-IE-2)94814Ventolin (sol neb 1x20 ml/100 mg (liek.skl.))4.12.2024R
 4.12.2024Viatris Healthcare Limited (VIM-1)1832AKombi-Kalz 500 mg/800 IU filmom obalené tablety (tbl flm 90x500 mg/800 IU (obal HDPE))5.12.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)